IMUX stock news · Immunic, Inc.

Stories about Immunic, Inc. (IMUX) from the last 90 days, each explained in plain English with whether the news reads good or bad for the company.

Get alerts for IMUX

Follow Immunic, Inc. (IMUX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Free on the App Store and Google Play, or on the web.

Nov 5, 2026, 9:15 AM ET · Market
Immunic, Inc. will hold a webinar on November 5, 2026, to share updates on its research and plans.
Neutral
Immunic announced a progressive multiple sclerosis research webinar and plans to use a presentation. No new study results are reported, so this does not change its outlook.
Sep 11, 2026, 6:17 PM ET · Market
Immunic, Inc. says Dr. Duane Nash left its Board, making it smaller from ten to nine members.
Neutral
Immunic reported a director resignation without disagreement; this appears routine and does not change the company's outlook.
Sep 9, 2026, 9:49 AM ET · Market
Immunic, Inc. says it will hold a webinar about its research on September 9, 2026.
Neutral
Immunic held an R&D Day presentation on relapsing MS; the filing is informational and does not change how we read the company.
Aug 11, 2026, 7:11 AM ET · Market
Immunic, Inc. discloses operational outcomes and financial status (IMUX).
Neutral
Immunic, Inc. has filed a Form 8-K detailing its results of operations and financial condition, which includes updates on management changes and compensatory arrangements. This information is crucial for investors to assess the company's current standing and future prospects.